Skip to main content
Fresenius SE & Co. KGaA logo

Fresenius SE & Co. KGaA — Investor Relations & Filings

Ticker · FRE ISIN · DE0005785604 LEI · XDFJ0CYCOO1FXRFTQS51 F Human health and social work activities
Filings indexed 1,398 across all filing types
Latest filing 2006-10-02 Investor Presentation
Country DE Germany
Listing F FRE

About Fresenius SE & Co. KGaA

https://www.fresenius.com/

Fresenius SE & Co. KGaA is a global healthcare company that provides system-critical products and services for leading therapies for the care of critically and chronically ill patients. The company's portfolio encompasses a wide range of products and services for dialysis, hospitals, and outpatient medical care. Key offerings include intravenously administered generic drugs, biopharmaceuticals, biosimilars, clinical nutrition, and infusion therapies. Additionally, the company operates a large network of private hospitals and outpatient centers. Through its strategic investment in Fresenius Medical Care, it is a leading global provider of products and services for individuals with renal diseases.

Recent filings

Filing Released Lang Actions
UBS Global Life Sciences Conference
Investor Presentation Classification · 100% confidence The document text consists of slides detailing financial results, outlook updates, and segment performance (Fresenius Medical Care, Fresenius Kabi, Fresenius ProServe). Key phrases include 'UBS – Global Life Science Conference September 25, 2006', 'H1 2006' financial tables, and raised '2006 Financial Outlook'. This structure—a presentation format with segment breakdowns and forward-looking guidance based on interim results (H1)—is characteristic of an Investor Presentation (IP) given at a conference, rather than a formal regulatory filing like a 10-K or an Earnings Release (ER) which is typically a press release format. Since the document is a detailed presentation, Investor Presentation (IP) is the most appropriate classification.
2006-10-02 English
Q2 Report 2006
Interim / Quarterly Report Classification · 100% confidence The document is a comprehensive quarterly report for the Fresenius Group covering the first half and second quarter of 2006. It contains detailed management discussion and analysis (MDA), consolidated financial statements (income statement, balance sheet, cash flow, etc.), segment reporting, and notes. It is clearly a substantive financial report for a period shorter than a full fiscal year, fitting the definition of an Interim/Quarterly Report (IR). H2 2006
2006-08-14 English
Fresenius AG: First half of 2006 - Firmly on growth track
Earnings Release Classification · 100% confidence The document is an 'Ad hoc announcement' dated August 3, 2006, detailing the financial results for the 'First half of 2006'. It provides key figures for Group sales, EBIT, net income, and earnings per share, and raises the full-year forecast. This content structure—a brief announcement summarizing period results and outlook—is characteristic of an Earnings Release (ER). It is not a comprehensive report (like 10-K or IR) nor a transcript (CT). Given its nature as an initial release of periodical financial results, ER is the most appropriate classification. H1 2006
2006-08-03 English
Analysts´ Meeting August 3, 2006
Investor Presentation Classification · 100% confidence The document is titled 'Analyst Meeting, August 3, 2006' and contains an 'Agenda' that includes 'Business Update', 'Fresenius Financials H1 2006', and 'Outlook 2006'. The content is highly structured with slides, figures, tables detailing sales, EBIT, and financial outlooks for H1 2006 across various business segments (Fresenius Kabi, Fresenius ProServe). This format, focusing on detailed financial performance review and forward guidance presented to analysts, strongly indicates an Investor Presentation (IP). It is not a formal regulatory filing like 10-K or IR, nor is it a brief announcement (RPA/ER).
2006-08-03 English
Mitteilung uber Geschafte von Fuhrungspersonen nach 15a WpHG
Director's Dealing Classification · 100% confidence The document is titled 'Directors’ Dealings' and contains the header 'Mitteilung über Geschäfte von Führungspersonen nach §15a WpHG' (Notification of transactions by persons discharging managerial responsibilities according to §15a WpHG). It explicitly details a 'Director's-Dealings-Mitteilung' regarding a purchase transaction by Stephan Sturm, a member of the managing body ('Geschäftsführendes Organ'). This directly corresponds to the definition of Director's Dealing.
2006-05-18 German
Q1 Report 2006
Interim / Quarterly Report Classification · 100% confidence The document is titled 'Quarterly Report of Fresenius Group' and explicitly covers the '1st Quarter 2006'. It contains detailed financial statements, management discussion and analysis (MD&A), segment reporting, and consolidated financial data. It is a comprehensive financial report for a period shorter than a full fiscal year, fitting the definition of an Interim/Quarterly Report (IR). Q1 2006
2006-05-15 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.